IGC Pharma, Inc. (IGC)
0.2597
0.00 (0.00%)
USD |
NYAM |
Feb 20, 16:00
0.265
+0.01
(+2.04%)
After-Hours: 18:04
IGC Pharma EPS Diluted (Quarterly) : -0.0201 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NRX Pharmaceuticals, Inc. | -0.2649 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.821M |
| Revenue (Quarterly) | 0.191M |
| Total Expenses (Quarterly) | 2.012M |
| Enterprise Value | 23.76M |
| Gross Profit Margin (Quarterly) | -3.14% |
| Profit Margin (Quarterly) | -953.4% |
| Earnings Yield | -29.96% |
| Normalized Earnings Yield | -29.92 |